These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19324308)

  • 1. Differential effects of cardiac sodium channel mutations on initiation of ventricular arrhythmias in patients with Brugada syndrome.
    Morita H; Nagase S; Miura D; Miura A; Hiramatsu S; Tada T; Murakami M; Nishii N; Nakamura K; Morita ST; Oka T; Kusano KF; Ohe T
    Heart Rhythm; 2009 Apr; 6(4):487-92. PubMed ID: 19324308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
    Tanaka M; Nakamura K; Kusano KF; Morita H; Ohta-Ogo K; Miura D; Miura A; Nakagawa K; Tada T; Murakami M; Nishii N; Nagase S; Hata Y; Kohno K; Ouchida M; Shimizu K; Yutani C; Ohe T; Ito H
    Cardiovasc Pathol; 2011; 20(1):e37-42. PubMed ID: 20219395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic characteristics of premature ventricular contractions in subjects with type 1 pattern of Brugada syndrome.
    Letsas KP; Asvestas D; Vlachos K; Karlis D; Korantzopoulos P; Efremidis M; Sideris A
    J Electrocardiol; 2014; 47(3):351-5. PubMed ID: 24636795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal transmural repolarization process in patients with Brugada syndrome.
    Sangawa M; Morita H; Nakatsu T; Nishii N; Miura D; Miura A; Tada T; Murakami M; Hiramatsu S; Nagase S; Nakamura K; Oka T; Toyonaga S; Mashima K; Kusachi S; Yamamoto K; Ohe T; Kusano KF
    Heart Rhythm; 2009 Aug; 6(8):1163-9. PubMed ID: 19632628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Amin AS; Reckman YJ; Arbelo E; Spanjaart AM; Postema PG; Tadros R; Tanck MW; Van den Berg MP; Wilde AAM; Tan HL
    Int J Cardiol; 2018 Sep; 266():128-132. PubMed ID: 29709244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.
    London B; Michalec M; Mehdi H; Zhu X; Kerchner L; Sanyal S; Viswanathan PC; Pfahnl AE; Shang LL; Madhusudanan M; Baty CJ; Lagana S; Aleong R; Gutmann R; Ackerman MJ; McNamara DM; Weiss R; Dudley SC
    Circulation; 2007 Nov; 116(20):2260-8. PubMed ID: 17967977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
    Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
    Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch.
    Hoogendijk MG; Potse M; Linnenbank AC; Verkerk AO; den Ruijter HM; van Amersfoorth SC; Klaver EC; Beekman L; Bezzina CR; Postema PG; Tan HL; Reimer AG; van der Wal AC; Ten Harkel AD; Dalinghaus M; Vinet A; Wilde AA; de Bakker JM; Coronel R
    Heart Rhythm; 2010; 7(2):238-48. PubMed ID: 20022821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities.
    Frigo G; Rampazzo A; Bauce B; Pilichou K; Beffagna G; Danieli GA; Nava A; Martini B
    Europace; 2007 Jun; 9(6):391-7. PubMed ID: 17442746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome.
    Nishii N; Ogawa M; Morita H; Nakamura K; Banba K; Miura D; Kumagai N; Matsunaga A; Kawamura H; Urakawa S; Miyaji K; Nagai M; Satoh K; Nakagawa K; Tanaka M; Hiramatsu S; Tada T; Murakami M; Nagase S; Kohno K; Kusano KF; Saku K; Ohe T; Ito H
    Circ J; 2010 Nov; 74(12):2572-8. PubMed ID: 21048329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
    Murakami M; Nakamura K; Kusano KF; Morita H; Nakagawa K; Tanaka M; Tada T; Toh N; Nishii N; Nagase S; Hata Y; Kohno K; Miura D; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):389-95. PubMed ID: 20625312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Brugada syndrome.
    Escárcega RO; Jiménez-Hernández M; Garcia-Carrasco M; Perez-Alva JC; Brugada J
    Acta Cardiol; 2009 Dec; 64(6):795-801. PubMed ID: 20128157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome.
    Akai J; Makita N; Sakurada H; Shirai N; Ueda K; Kitabatake A; Nakazawa K; Kimura A; Hiraoka M
    FEBS Lett; 2000 Aug; 479(1-2):29-34. PubMed ID: 10940383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic change in ST-segment and spontaneous occurrence of ventricular fibrillation in Brugada syndrome with a novel nonsense mutation in the SCN5A gene during long-term follow-up.
    Kawamura M; Ozawa T; Yao T; Ashihara T; Sugimoto Y; Yagi T; Itoh H; Ito M; Makiyama T; Horie M
    Circ J; 2009 Mar; 73(3):584-8. PubMed ID: 19075524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope.
    Makita N; Sumitomo N; Watanabe I; Tsutsui H
    Heart Rhythm; 2007 Apr; 4(4):516-9. PubMed ID: 17399644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation.
    Hasebe H; Yokoya T; Murakoshi N; Kurebayashi N
    Intern Med; 2020 Jan; 59(1):83-87. PubMed ID: 31484910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction.
    Hu D; Viskin S; Oliva A; Carrier T; Cordeiro JM; Barajas-Martinez H; Wu Y; Burashnikov E; Sicouri S; Brugada R; Rosso R; Guerchicoff A; Pollevick GD; Antzelevitch C
    Heart Rhythm; 2007 Aug; 4(8):1072-80. PubMed ID: 17675083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.